LMRI Earnings Date: Nov 10, 2026 (Estimated) — Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ
Updated
When is LMRI's next earnings date?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 8:07 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.20 on revenue of $270.3M.
How did LMRI do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Lumexa Imaging Holdings, Inc. Common Stock posted EPS of $0.20 versus the $0.15 estimate, a beat of 66.7%. Revenue was $264.2M against a $263.1M estimate. The stock's 1-day post-earnings move was +4.0%.
How much does LMRI stock move after earnings?
LMRI beat EPS estimates in 2 of its last 3 reported quarters. Over the last 3 reports the stock moved an average of 19.1% (up or down) in the day after earnings.
About Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | 0.15 | 0.20 | +66.67% | $264.2M | ✅ Beat | +4.01% | +1.02% | -2.05% |
| 2026-05-12 | Q1 2026 | 0.10 | 0.18 | +80.00% | $252.5M | ✅ Beat | -23.33% | -33.33% | -9.33% |
| 2026-03-26 | Q4 2025 | 0.05 | -0.20 | -500.00% | $267.7M | ❌ Miss | -29.84% | -15.01% | -13.20% |
Showing last 3 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $203.6M total
| Segment | Share | Revenue | YoY | Q2 FY26 |
|---|---|---|---|---|
| Health Care, Patient Service | 95.7% | $194.9M | — | $194.9M |
| Investment Advisory, Management and Administrative Service | 4.3% | $8.7M | — | $8.7M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.